Evidence map›Paper›PMID 34336894›Full record

ArticleFrontiers in medicine2021

Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial.

Xu Shu, Zhenhua Zhu, Yu Fu, Zhenyu Zhang, Jiangbin Wang, Xing Li, Shuixiang He, Huizhen Fan, Side Liu, Guoxin Zhang and 14 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 19 institutions in 1 country.

Xu ShuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhenhua ZhuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yu FuDepartment of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhenyu ZhangDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Jiangbin WangDepartment of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, China.
Xing LiDepartment of Gastroenterology, Jiangxi Pingxiang People's Hospital, Pingxiang, China.
Shuixiang HeDepartment of Gastroenterology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Huizhen FanDepartment of Gastroenterology, Yichun People's Hospital, Yichun, China.
Side LiuDepartment of Gastroenterology, Nanfang Hospital, Nanfang Medical University, Guangzhou, China.
Guoxin ZhangDepartment of Gastroenterology, Jiangsu Province Hospital, Nanjing, China.
Jianhua TangDepartment of Gastroenterology, Ganzhou People's Hospital, Ganzhou, China.
Caibin HuangDepartment of Gastroenterology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Qin DuDepartment of Gastroenterology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xiaoyan WangDepartment of Gastroenterology, The Third Hospital of Central South University, Changsha, China.
Baohong XuDepartment of Gastroenterology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Yiqi DuDepartment of Gastroenterology, Changhai Hospital, Shanghai, China.
Qikui ChenDepartment of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Bangmao WangDepartment of Gastroenterology, Tianjin Medical University General Hospital, Tianjin, China.
Ying ChenClinical Development, Xuanzhu Biopharmaceutical Co., Ltd., Beijing, China.
Xianghui DuanStatistics, Xuanzhu Biopharmaceutical Co., Ltd., Beijing, China.
Yong XieDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Lijuan HuoDepartment of Gastroenterology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Xiaohua HouDepartment of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Nonghua LuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Nanchang University · CNHuazhong University of Science and Technology · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CNCentral South University · CNChanghai Hospital · CNFirst Affiliated Hospital of Gannan Medical University · CNFirst Affiliated Hospital of Nanchang University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNGanzhou People's Hospital · CNJiangsu Province Hospital · CNJiangxi Pingxiang People's Hospital · CNJilin University · CNNanfang Hospital · CNNanjing Medical University · CNSecond Affiliated Hospital of Zhejiang University · CNShanxi Medical University · CNSun Yat-sen University · CNTianjin Medical University General Hospital · CNYichun University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anaprazoleduodenal ulcerpeptic ulcerproton pump inhibitorsrabeprazole

Identifiers

PMID34336894
PMCPMC8317206
OpenAlexW3178898736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.